Loading stock data…
Loading stock data…
US$1.09
Get one email when FLNA crosses your level. Checked every 15 minutes during market hours.
▲ +0.01 (0.93%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
35.0
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.06
Bearish momentumMACD below its signal line (-0.05).
50-day average
1.27
Price belowShort-term trend reference.
200-day average
2.18
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Filana Therapeutics is a biotechnology company focused on developing novel investigational therapies that modulate the filamin A protein for treating central nervous system disorders. The company's primary focus is on tuberous sclerosis complex (TSC)-related epilepsy and other conditions associated with filamin A dysregulation or overexpression. Headquartered in Austin, Texas, and founded in 1998, Filana Therapeutics operates in the clinical development stage, working to advance its pipeline of …
www.filanatx.com2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2026-03-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2026-02-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2026-01-01)
2 strong buy · 4 buy · 2 hold · 0 sell · 0 strong sell (8 analysts, 2025-12-01)
Companies in the same industry, via Finnhub